Extracellular matrix-mediated control of aortic smooth muscle cell growth and migration by a combination of ascorbic acid, lysine, proline, and catechins

Journal of Cardiovascular Pharmacology

Volumn 50, Issue 5, 2007, Pages 541-547

  Ivanov, Vadim ^a   Ivanova, Svetlana ^a   Roomi, M Waheed ^a   Kalinovsky, Tatiana ^a   Niedzwiecki, Aleksandra ^a,b   Rath, Matthias ^a  

^a Dr Rath Research Institute   (United States)

^b NONE   (United States)

Author keywords

Aortic smooth muscle cell; Ascorbic acid; Catechins; Extracellular matrix; Lysine; Proline

Indexed keywords

ASCORBIC ACID; CATECHIN; LYSINE; PROLINE;

AORTA; ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; CELL ACTIVITY; CELL FUNCTION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; SMOOTH MUSCLE FIBER;

AMINO ACIDS; ANTIOXIDANTS; AORTA; ASCORBIC ACID; CAMELLIA SINENSIS; CATECHIN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHONDROITIN SULFATES; COLLAGEN TYPE I; COLLAGEN TYPE III; COLLAGEN TYPE IV; ELASTIN; EXTRACELLULAR MATRIX; FIBRONECTINS; FLAVONOIDS; HEPARITIN SULFATE; HUMANS; LAMININ; LYSINE; MYOCYTES, SMOOTH MUSCLE; PLANT EXTRACTS; PROANTHOCYANIDINS; PROLINE;

EID: 36348931573     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318145148e     Document Type: Article

References (28)

1. Rath M. Reducing risk for cardiovascular disease with nutritional supplementation. J Orth Med. 1992;7:153-162.
2. McCarty MF. An expanded concept of "insurance" supplementation-broad spectrum protection from cardiovascular disease. Med Hyptheses. 1981;10:1287-1302.
3. Rath M, Pauling L. Solution to the puzzle of human cardiovascular disease: its primary cause is ascorbate deficiency, leading to the deposition of lipoprotein(a) and fibrinogen/fibrin in the vascular wall. J Ortho Med. 1991;6:125-134.
4. Tinker D, Rucker RB. Role of selected nutrients in synthesis, accumulation, and chemical modification of connective tissue proteins. Physiol Rev. 1985;65:607-657.
5. Geesin JC, Hendricks LJ, Gordon JS, et al. Modulation of collagen synthesis by growth factors: the role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys. 1991;289:6-11.
6. Murata K, Motayama T, Kotake C. Collagen types in various layer of the human aorta and their changes with the atherosclerotic process. Atherosclerosis. 1986;60:251-262.
7. Katsuda S, Okada Y, Minamoto T, et al. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler Thromb Vasc Biol. 1992;12:494-502.
8. Ross R, Wright TN, Strandness E, et al. Human atherosclerosis: 1 Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Path. 1984;114:79-93.
9. Wagner WD. Proteoglycan structure and function as related to atherosclerosis. Ann N Y Acad Sci. 1985;454:52-68.
10. Voelker W, Schmidt A, Oortmann W, et al. Mapping of proteoglycancs in atheorsclerotic lesions. Eur Heart J. 1990;11:29-40.
11. Tammi M, Seppala PO, Lhtonen A, et al. Connective tissue components in normal and atherosclerotic human coronary arteries. Atherosclerosis. 1978;29:191-194.
12. Pillarisetti S, Paka L, Obunike JC, et al. Subendothelial retention of lipoprotein(a): evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. J Clin Invest. 1997;100:867-874.
13. Ivanov V, Roomi MW, Kalinovsky T, et al. Antiatherogenic effects of a mixture containing ascorbic acid, lysine, proline, arginine, cysteine and green tea phenolics: in vitro study using human aortic smooth muscle cells. J Cardiovasc Pharmacol. 2007;49:140-145.
14. Ivanov V, Ivanova SV, Niedzwiecki A. Ascorbate affects proliferation of guinea-pig vascular smooth muscle cells by direct and extracellular matrix-mediated effects. J Mol Cell Cardiol. 1997;29:3293-3303.
15. Rekhter MD, Zhang K, Narayana AS, et al. Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am J of Path. 1993;143:1634-1648.
16. Watson KE, Parhami F, Shin V, et al. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol. 1998;18:1964-1971.
17. Rath M and Niedzwiecki A. Nutritional supplement halts progression of early coronary atherosclerosis. J of Appl Nutr. 1996;48:67-78.
18. Nakazawa K, Murata K. Comparative study of the effects of chondroitin sulfate isomers on atherosclerotic subjects. ZFA. 1979;34:153-159.
19. Theocharais AD, Theocharis DA, De Luca G, et al. Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurismal dilatation of the human abdominal aorta. Biochimie. 2002;84:667-674.
20. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002;8:1249-1256.
21. Nakata Y, Maeda N. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid. Circulation. 2002;105:1485-1490.
22. Munrad S, Grove D, Lindberg KA, et al. Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci USA. 1981;78:2879-2882.
23. Arakawa E, Hasegawa K, Irie J, et al. L-ascorbic acid stimulates expression of smooth muscle-specific markers in smooth muscle cells both in vitro and in vivo. J Cardiovasc Pharmacol. 2003;42:745-751.
24. Rath M, Pauling L. A unified theory of human cardiovascular disease leading the way to the abolition of this disease as a cause for human mortality. J Ortho Med. 1992;7:5-15.
25. Sasazuki, S, Kodama H, Yoshimasu K, et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol. 2000;10:401-408.
26. Miura Y, Chiba T, Tomita I, et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001;131:27-32.
27. Riemersma RA, Wood DA, Macintyre CC, et al. Risk of angina pectoris and plasma concentrations of vitamin A, C, and E and carotene. Lancet. 1991;337:1-5.
28. Hodis HN, Mack WJ, La Bree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA. 1996;273:1849-1854.